$SIBN

DUNN JEFFREY W sold $55K of SIBN

DUNN JEFFREY W sold 3,575 shares of SI-BONE, Inc. (SIBN) at $15.25 on 2026-06-05.

Original reporting
SEC EDGAR · DUNN JEFFREY W
Published Jun 8, 2026, 9:43 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SIBN
Neutral
medium confidence
Mentioned
$SIBN
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SIBNNeutralLow
01

Why it matters

The article provides a fresh, primary-source datapoint on insider behavior (director sale size, price, and post-transaction holdings).

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a sustained repricing without other catalysts.

03

What to watch

Check whether other insiders are selling/buying around the same window and whether the company has upcoming catalysts (earnings, trial updates) not mentioned here.

Relevance 3/10Novelty 8/10Timing: Filed 2026-06-08 for a 2026-06-05 insider sale

Background

This is an SEC Form 4 insider transaction disclosure for SI-BONE, Inc.

Company-level read

Ticker impact

$SIBNNeutralMedium confidence
Context

SI-BONE director Jeffrey W. Dunn sold 3,575 shares in an open-market transaction at $15.2462 on 2026-06-05.

Expected impact

Likely limited immediate impact; any effect would be sentiment-driven and small unless follow-on selling or new fundamentals emerge.

Evidence & confidence

The filing is a routine Form 4 insider sale with no 10b5-1 plan stated and no accompanying company-specific catalyst in the article.

Market effects

No clear sector read-through from a single director open-market sale.

None indicated.

None indicated.

Counterpoint

The sale may be for diversification, taxes, or pre-planned liquidity needs; without a 10b5-1 plan, it still may not signal negative fundamentals.

Key entities

  • SI-BONE, Inc.

    Company whose director sold shares; subject of the Form 4 disclosure.

  • Jeffrey W. Dunn

    Director who executed the open-market sale of 3,575 shares.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_q226earningsrel.htm EX-99.1 Document Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Q